Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC
Sponsor: Huabo Biopharm Co., Ltd.
Summary
This trial is a Phase II study. The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of HB0025 administered with chemotherapy in participants with locally advanced or metastatic triple-negative breast cancer (TNBC) who have not received prior systemic therapy for metastatic breast cancer (mBC).
Official title: A Phase II Study of HB0025 in Combination With Nab-Paclitaxel as First Line Therapy for Unresectable, Locally Advanced or Metastatic Triple-negative Breast Cancer.
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2025-08-14
Completion Date
2027-01-15
Last Updated
2026-01-29
Healthy Volunteers
No
Conditions
Interventions
HB0025 20 mg/kg plus nab-paclitaxel
HB0025 20 mg/kg
HB0025 10 mg/kg plus nab-paclitaxel
HB0025 10 mg/kg
Locations (23)
Anyang Cancer Hospital
Anyang, China
Xiangya Hospital Central South University
Changsha, China
Sichuan Cancer Hospital
Chengdu, China
Fujian Cancer Hospital
Fujian, China
Guangdong Provincial People's Hospital
Guangdong, China
Sun Yat-sen University Cancer Center
Guangzhou, China
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, China
Harbin Medical University Cancer Hospital
Harbin, China
Anhui Provincial Hospital
Hefei, China
The First Hospital of Jilin University
Jilin, China
Affiliated Hospital of Jining Medical University
Jining, China
Linyi Cancer Hospital
Linyi, China
Jiangsu Province Hospital
Nanjing, China
Shandong Cancer Hospital
Shandong, China
Fudan University Shanghai Cancer Center
Shanghai, China
Shanxi Cancer Hospital
Shanxi, China
Liaoning Cancer Hospital
Shengyang, China
The Second Affiliated Hospital of Soochow University
Suzhou, China
Tianjin Cancer Hospital
Tianjing, China
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, China
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
The First Affiliated Hospital of Xiamen University
Xiamen, China
Xuzhou Central Hospital
Xuzhou, China